Windham Capital Partners — Full Portfolio

Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.

BiotechDigital HealthMental HealthMountain View, US

Amit Etkin(Founder)inAdam Savitz(Executive Officer)Nicholas C. Smith(Executive Officer)Michael Hanley(Executive Officer)Aaron Weaver(Director)Po Yu (Jeff) Chen(Director)

Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesKorify CapitalVivo Capital+2 more

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)

BoardGeoff Pardo(Director)

Co-investorsNew Enterprise Associates (NEA)Treo Ventures, LlcYsios CapitalHatteras Venture PartnersVensana Capital

Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer.

BiotechHealthtechMedical Devices

William F. Doyle(Executive Chairman)Frank Leonard(Chief Executive Officer)

Co-investorsPfizer Venture Investments

Andros provides data-driven provider network management solutions for healthcare organizations, offering strategic and execution support across the full network lifecycle.

Enterprise SoftwareHealthtechSaaSNew York City, US

Andrew Camel(Founder)inMike Simmons(Founder)

Co-investorsBowery CapitalMeridian Street CapitalQuesta CapitalPrimary Venture Partners

Mentorship-driven startup accelerator for health technology entrepreneurs with funding and co-working space.

Blueprint Health is a healthcare-focused accelerator that runs a three-month program helping startups gain customers, raise capital, and refine their investor pitch.

Digital HealthHealthtech

HealthtechAlpharetta, US

Carribeth Ramey(Executive Officer)Peter J. Pizzo(Executive Officer)Robert R. Singer(Executive Officer)Deborah Moore(Executive Officer)Timothy Patrick(Executive Officer, Director)Peter J. Pizzo, III(Executive Officer)

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)

BoardJustin Klein(Director)in

Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Domain AssociatesDomain Partners+2 more

Medical device company developing the HARMONI Modular Intra-Ocular System for vision optimization in cataract surgery.

Medicare Advantage plan offering culturally sensitive healthcare combining Eastern and Western medicine.

Co-investorsFigure 8 InvestmentsGV (Google Ventures)PruVen Capital Partners

Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.

HealthtechInsurTechSouthern California, US

Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)

Co-investorsNorwest Venture PartnersGlobal Founders CapitalGV (Google Ventures)Novo HoldingsAV8 VenturesFigure 8 Investments+1 more

HealthtechRadnor, US

Guillaume Bailliard(Executive Officer, Director)

BoardSteven Nichtberger(Director)Amir Yaron(Director)Harlan Weisman(Director)Allon Guez(Director)Haim Melman(Director)

Co-investorsQuesta Capital

Coravin makes a wine-preservation system that uses a thin needle and Argon gas to pour wine without removing the cork, keeping the remaining wine fresh for weeks to years.

ConsumerDirect to ConsumerHardwareBurlington, US

Greg Lambrecht(Executive Officer, Director)Greg Lembrecht(Director)Frederic Levy(Executive Officer, Director)Nicholas Lazaris(Executive Officer, Director)Calli Prendergast(Executive Officer)Dave Krupinskiin

Co-investorsAlpine MeridianNew Enterprise Associates (NEA)

New York, US

Joseph Mayer(Director)James Bradley(Director)Bharath Ganesan(Director)Richard Resnick(Executive Officer, Director)

BoardJohn Clarke(Director)inTodd Pietri(Director)

Co-investorsCardinal PartnersActivate Ventures

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US

Victor Velculescu(Executive Officer, Director, Promoter)inPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)

BoardRishi Gupta(Director)in

Co-investorsAV8 VenturesForesite CapitalIllumina VenturesMenlo VenturesOpen Field CapitalOrbiMed+3 more

Detection on the Spot technology for food allergen detection spanning industrial and consumer applications.

Co-investorsNew Enterprise Associates (NEA)

Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.

HardwareHealthtechMedical DevicesMenlo Park, US

Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)Brent Edwards(Executive Officer)Greg Koskowich(Executive Officer)

Co-investorsAisling CapitalNew Enterprise Associates (NEA)Lightstone VenturesSightLine Partners

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program.

BiotechHealthtechMedical DevicesPhiladelphia, US

Co-investorsLG Technology VenturesNovartis Venture FundOrbiMedPontifax Venture CapitalSR One Capital ManagementMedicxi+1 more

HealthtechSan Diego, US

JOSEPH Y. LUCISANO(CHIEF TECHNOLOGY OFFICER)WILLIAM H. MARKLE(PRESIDENT AND CEO)

BoardADAM E. FINE(Director)inSAMUEL V. GOEKJIAN(Director)ROBERT L. ENGLER(Director)ORVILLE G. KOLTERMAN(Director)

Sophisticated optics for illumination and enhanced visualization in surgical procedures.

HealthtechSan Francisco, US

Kenneth Trauner(Executive Officer, Director)Alex Vayser(Executive Officer)Philip Sawyer(Executive Officer, Director)Theresa Brandner-Allen(Executive Officer)Brett Robertson(Executive Officer)Doug Rimer(Executive Officer)

Co-investorsKleiner PerkinsValence Advantage Life Sciences

Locemia is developing a needle-free glucagon nasal powder for treating severe hypoglycemia (severe low blood sugar) in insulin users, designed to be simple to teach, carry, and use.

BiotechDigital HealthMedical Devices

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)

BoardMarc Singer(Director)in

Co-investorsBraemar Energy VenturesMitsui Global InvestmentOUP (Osage University Partners)North Bridge Venture Partners

Nebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA.

BiotechConsumerDigital Health

George Church(Founder)

Co-investorsF-Prime CapitalHemi Ventures, LlcHikma Ventures

HealthtechPleasanton, US

Theodore Lamson(Director)Ted Lamson(Founder)inDavid Amerson(Executive Officer, Director)William Facteau(Director)Joshua Makower(Director)

BoardRyan Drant(Director)

Co-investorsNew Enterprise Associates (NEA)

Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.

BiotechHealthtechMedical DevicesSan Jose, US

Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)Dave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)

Co-investorsCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcAction Potential Venture Capital Ltd.Vertex Ventures HC

Aytu BioPharma is a pharmaceutical company developing treatments for complex central nervous system (CNS) conditions, including major depressive disorder (MDD) and ADHD.

BiotechHealthtechMountain View, US

Joshua Makower(Executive Officer, Director)Stefano Curti(Executive Officer, Director)

BoardDavis Yang(Director)John Nehra(Director)Yi Li(Director)Ryan Drant(Director)

Co-investorsRuvento Ventures Pte Ltd.

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).

HardwareHealthtechMedical DevicesMinneapolis, US

Martin Mayse(Co-founder)Steve Dimmer(Co-founder)Dennis Wahr(President & CEO)Lisa Flaherty(Chief Strategy Officer)Steve Sathre(Vice President of Finance)Steve Paidosh(Vice President of Operations)

Co-investorsLightstone VenturesQiming Venture Partners

PainTEQ develops medical devices and implants for sacroiliac joint dysfunction, offering solutions ranging from biologicalbone allografts to titanium implants as alternatives to injections or fusion surgery.

Deep TechHealthtechMedical DevicesTampa, US

Shanth(Chief Executive Officer)

Co-investorsSignet Healthcare Partners

A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.

BiotechDigital HealthHealthtechMedical DevicesBaltimore, US

Victor Velculescu(Executive Officer, Director, Promoter)Luis A. Diaz, Jr.(Executive Officer, Director, Promoter)Sam Angiuoli(Executive Officer)Sian Jones(Executive Officer)Lisa Kann(Executive Officer)Anthony Newton(Executive Officer)

Co-investors3B Future Health FundCatalio Capital Management, LPCo-Win VenturesNew Enterprise Associates (NEA)Vensana Capital

Stryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers.

Advanced ManufacturingHealthtechMedical Devices

Kevin Loboin

Co-investorsGefinor CapitalLumira VenturesNew Enterprise Associates (NEA)Rex Health Ventures

Revelle Aesthetics develops and commercializes the Avéli device, a precision medical technology for cellulite reduction.

FemTechMedical Devices

Eb Bright(Co-Founder and Chief Administrative Officer)Jonathan Podmore(Co-Founder and Chief Technology Officer)

Co-investorsNew Enterprise Associates (NEA)Runway Growth Capital

RxWare is a "Service as a Software" company that uses its AI-powered intelligence engine, RxWare OS, to move patients from prescription to first fill by providing real-time visibility and coordinated intervention across the patient access journey.

AI & Machine LearningDigital HealthHealthtechWilmington, US

Raeanna Lewarne(Executive Officer, Director)Shlomi Aflalo(Executive Officer, Director)Ori Karev(Director)Yishai Knobel(Executive Officer, Director)

BoardAdam Fine(Director)inGregg Dearhammer(Director)

Co-investorsVodia VenturesZORA

Science Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.

BiotechEnterprise SoftwareHealthtechSaaSSan Francisco, US

Elizabeth Iorns(Founder/President & CEO; Chairman of the Board)inDan Knox(Founder & COO)inMark Layden(CEO & Chairman)

Co-investorsIndex VenturesNorwest Venture PartnersSpider CapitalUnion Square Ventures (USV)Y CombinatorCollaborative Fund+1 more

SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors.

BiotechDigital HealthHealthtech

Co-investorsAsset Management CompanyATPGeekdomHealthy VenturesMartin Ventures

TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.

Digital HealthHealthtechSaaS

Adam Siton(Founder)inIsrael (Srulik) Dvorsky(Founder)in

Co-investorsAccelmed PartnersAllumia VenturesBallad VenturesBridges IsraelOSF VenturesSamsung Next+2 more

Co-investorsCorewell Health Ventures

Valera Health provides virtual mental health care for adults and children, connecting patients with vetted in-house providers who develop personalized, data-driven treatment plans.

Digital HealthHealthtechMental HealthBrooklyn, US

Thomas Tsang(Executive Officer, Director)Dr. Thomas TsangCraig Albright(Executive Officer, Director)Arick Rynearson(Director)Ofer Sharon(Director)

BoardAdam Fine(Director)in

Co-investorsConnecticut InnovationsCorewell Health VenturesCU Healthcare Innovation FundFigure 8 InvestmentsGreyMatterMedStartr Ventures+2 more

Vergent Bioscience is a clinical-stage biotechnology company developing abenacianine (VGT-309), a tumor-targeted fluorescent imaging agent that helps surgeons see tumors in real time during minimally invasive and robotic-assisted surgery.

BiotechHealthtechMedical DevicesMinneapolis, US

Jeffrey Yurecko(Executive Officer)John Santini(Executive Officer, Director)

BoardJeff Julkowski(Director)Raymond Wong(Director)Anita Watkins(Director)Samuel Dean Banks(Director)

Co-investorsColle Capital PartnersSpring Mountain Capital

HealthtechSunnyvale, US

John Pavlidis(Executive Officer, Director)Michael Horzewski(Executive Officer, Director)Michael Pederson(Executive Officer, Director)

BoardDavid McIntyre(Director)Justin Klein(Director)Sami Hamade(Director)

Co-investorsNew Enterprise Associates (NEA)BioStar Ventures

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)

Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+1 more

Willow makes breast pumps and pumping accessories for nursing mothers, including in-bra wearable pumps and collection cups that convert traditional electric pumps into hands-free devices.

ConsumerDirect to ConsumerFemTechHardware

Co-investorsNew Enterprise Associates (NEA)PortfoliaBoxGroupBurst CapitalGoodwater CapitalHetz Ventures+1 more

Co-investorsLightstone Ventures